Abstract-The association between plasma apolipoprotein (apo) B concentrations and angiographically determined coronary artery disease (CAD) was investigated in women in a cross-sectional study. Stenosis of Ͼ60% in 1 or more coronary arteries was classified as CADϩ. CADϪ was defined as a maximum stenosis of 10% in any coronary artery. Data on apoB as a risk indicator for CAD in women are limited.
T he atherogenic lipoprotein particles LDL, VLDL remnants, or IDL, and chylomicron remnants each contain 1 molecule of apoB as the structural protein. The plasma apoB concentration reflects the number of atherogenic lipoproteins, and studies in men have demonstrated that apoB can be a valuable predictor for CAD. 1, 2 Data on apoB as a risk indicator for CAD in women are limited. 1 Although CAD is the major cause of death in women, the absolute numbers of clinical manifestations of CAD are low. [3] [4] [5] [6] Thus, long-term studies in large numbers of women are required to evaluate the impact of risk factors on CAD. Studies with surrogate end points, such as coronary angiograms, are useful.
ApoB has been associated with angiographically determined CAD in a small group of Asiatic women 7 and in women with premature (Ͻ60 years) CAD. 8 ApoB was also related to CAD in a larger angiography study that included women on lipid-lowering medication and women for whom nonfasting lipid measurements were available. 9 Fasting plasma samples are essential for comparison between different lipid parameters because TG concentrations increase 10 -12 and HDL-chol concentrations decrease in the postprandial state in both men 10 and women. 11, 13 In the current angiography study in a large group of women, only fasting plasma samples were used for determination of lipids and apolipoproteins. Angiographies were performed in a community-referral hospital. No age or lipid selection criteria were used in an attempt to obtain a representative sample of women from the general population referred for angiography. We investigated whether apoB was an independent risk factor for CAD and whether apoB was superior to chol, LDL-chol, HDL-chol, TG, or apoA-I in discriminating between CADϩ and CADϪ women. Frequency distributions of age, lipids, and apolipoproteins in CADϩ and CADϪ women were also obtained.
Methods

Design
This cross-sectional study was performed in a community-referral cardiology clinic in the southwestern part of the Netherlands, the Oosterschelde Hospital Goes. The study protocol was approved by the Ethics Committee of the hospital, and all subjects gave their informed consent before participation in the study.
Study Population
The study population consisted of women who were undergoing their first coronary angiography between January 1992 and January 1997. The indications for angiography were suspicion of CAD or preoperative screening for CAD in subjects with valvular disease. Women undergoing elective angiographies were included to avoid the influence of stress situations, such as a myocardial infarction, on plasma lipids. Women using lipid-lowering medication were excluded from analysis. Plasma concentrations of chol, TGs, HDL-chol, LDL-chol, apoA-I, and apoB were determined after an overnight fast during the week preceding the angiography.
Angiography
Coronary angiographies were performed according to the standard Judkins technique.
14 Women were classified as CADϩ if 1 or more coronary arteries had a stenosis Ͼ60% on visual examination. The other women were classified as CADϪ.
Lipids and Apolipoproteins
Chol and TG concentrations were measured enzymatically (Vitros analyzer, Johnson & Johnson). HDL-chol fractions were prepared by precipitation from plasma of the apoB-containing lipoproteins with the use of dextran sulfate and MgCl 2 .
10 Plasma LDL-chol was calculated by using the Friedewald formula (total cholϪ[HDLchol]Ϫ[0.45ϫTG]). ApoA-I and apoB were measured by immunonephelometry on a Beckman array protein system. Beckman reagents, calibrators, and standards were used. From June 1995 onward, the reference values for apoB were changed as a result of international standardization according to IFCC/WHO standards (SP3-07). The assigned values according to IFCC/WHO standards for apoB after June 1995 were identical to those before June 1995 multiplied by 0.82. In the current study the old values were converted to new values. ApoA-I reference values, based on SP1-01, did not change.
Clinical and Lifestyle Characteristics
Questionnaires were sent to the participants to retrospectively obtain self-reported information about clinical and lifestyle characteristics during the year preceding coronary angiography. Height and weight were recorded. Women were classified as never-smokers, past smokers, or current smokers. Diabetes was diagnosed as non insulin-dependent if the age of onset was Ͼ30 years and the first treatment was with diet modification or oral hypoglycemic medication. Diabetes was diagnosed as insulin dependent if the age of onset was Ͻ20 years and the first treatment was with insulin. The diagnosis of diabetes with an onset between 20 and 30 years of age was obtained from the patient's records. Women were diagnosed as hypertensive if a physician had told them they had hypertension or if they were using antihypertensive medication. Family history was considered positive if at least 1 of the parents, siblings, or children had manifestations of cardiovascular disease before the age of 60 years. Ages at menarche and, if appropriate, at menopause (surgical or natural) were recorded. Finally, the premenopausal use of oral contraceptives and the postmenopausal use of HRT in any form were recorded.
Statistics
Logistic regression was used to analyze the influence of continuous and dichotomous variables on the presence of CAD (the dependent variable 
Results
Subjects
In the 5-year interval between 1992 and 1997, 289 women met the inclusion criteria. By January 1997, 10 women had died and 3 women were considered ineligible to fill out the questionnaire (according to their general practitioners) because of dementia, hypochondria, and analphabetism, respectively. Seven women had changed their places of residence without leaving their new addresses. Two hundred sixty-nine questionnaires were mailed, and 235 (87%) were returned and adequately filled out. Therefore, information on nonlipid risk factors was available for 235 of the 289 women (81%). The women who did not receive or return questionnaires (nϭ57) were older than the responders (64.33Ϯ9.68 versus 61.12Ϯ9.95 years, Pϭ0.028), but the plasma concentrations of chol, TGs, LDL-chol, HDL-chol, apoA-I, and apoB and the distribution of CADϪ and CADϩ were similar in both groups (Student's t tests for independent samples). Therefore, we assumed that the questionnaire group was representative of the entire study population so far as lipids, apolipoproteins, and CAD were concerned.
Angiography
The CADϪ group consisted of 129 women. The indications for angiography in the CADϪ group were suspicion of CAD (81%) or preoperative screening for CAD in valvular disease (19%). All CADϪ women only had vascular wall irregularities and stenosis Ͻ10%. The CADϩ group consisted of 160 women, and the indications for angiography in the CADϩ group were suspicion of CAD (98%) or preoperative screening for CAD in valvular disease (2%). The CADϩ group was further divided into 1-vessel (nϭ78), 2-vessel (nϭ41), and 3-vessel (nϭ32) disease groups. Nine women had a stenosis in the left main coronary artery.
Clinical and Lifestyle Characteristics
CADϩ women were significantly older than CADϪ women. Non-insulin-dependent diabetes mellitus was present in 24 women and insulin-dependent diabetes mellitus in 1 CADϩ woman. Both forms of diabetes were pooled for analysis (Table 1) . Diabetes, smoking, and hypertension were significantly associated with CADϩ after correction for age. The body mass index was not different between CADϪ (25.94Ϯ4.33 kg/m 2 ) and CADϩ (26.24Ϯ4.04 kg/m 2 ) women. Premature CAD, diagnosed as disease onset at Ͻ60 years of age, was present in 26.3% of CADϩ women. In the normolipidemic subgroup, defined as chol Ͻ6.5 mmol/L and TG Ͻ2.3 mmol/L, CAD was associated with age (Pϭ0.008), but after correction for age, smoking was the only nonlipid risk factor that was significantly associated with CAD (Pϭ0.03).
Selected Abbreviations and Acronyms
CADϩ, CADϪ ϭ with, without coronary artery disease chol ϭ cholesterol HRT ϭ hormone replacement therapy TG ϭ triglyceride
Hormonal Status
The majority of the women (88.5%) were postmenopausal. The age at menopause was 49.17Ϯ4.3 years for women with a natural menopause (nϭ168) and 41.65Ϯ7.3 years for women with surgical menopause (nϭ23) ( Table 1) . After correction for age, postmenopausal status (natural or surgical) was no longer a predictor of CAD. Ever-use of HRT was associated with reduced CAD (Pϭ0.012), but after correction for age, this was no longer significant (Pϭ0.07). Only 12.4% of the postmenopausal women had ever used HRT in any form, and the mean duration of HRT was 3.2Ϯ4.0 years (range, 0.2 to 16). Twenty percent of the postmenopausal women had undergone hysterectomy.
Lipids and Apolipoproteins
Plasma chol concentrations in 5-year age categories of the entire study group were in the same range as chol concentrations in Dutch women from the general population (Tables 2,  3 , and 4 and Figure 1) . 15, 16 Fasting plasma concentrations of chol, LDL-chol, TGs, and apoB were significantly higher and HDL-chol was significantly lower in CADϩ women than in CADϪ women (Table 2) , and this association remained so after correction for age. The extent of CAD, expressed as the number of stenotic coronary arteries, was associated with chol, LDL-chol, apoB, and age. After correction for age, apoB remained the most significant parameter (Table 3 ). In a normolipidemic subgroup (chol Յ6.5 mmol/L and TGs Յ2.3 mmol/L), apoB and LDL-chol were the only parameters associated with CAD after correction for age (Table 4) .
Each lipid parameter was an independent risk factor for CAD (logistic regression). After correction for confounders in clinical and lifestyle characteristics, the odds ratios for CAD were 11.1 for apoB (g/L), 1.5 for chol (mmol/L), 1.66 for LDL-chol (mmol/L), 0.68 for HDL-chol (mmol/L), and 5.1 for log TGs (log scale). Owing to differences in the units of measure, odds ratios cannot be directly compared. Therefore, lipid and apolipoprotein parameters were divided into quartiles. In any quartile of apoB, no significant differences between CADϪ and CADϩ women were observed for chol, LDL-chol, HDL-chol, or TG. In contrast, apoB was signifi- cantly higher in CADϩ than in CADϪ women in the lowest quartiles of chol, LDL-chol, and log TG, and there was a trend toward higher apoB levels in CADϩ versus CADϪ in the highest HDL-chol quartile (Figure 1 ). In addition, apoB was significantly higher in CADϩ versus CADϪ in the second and fourth log TG quartiles, in the fourth LDL-chol quartile, in the fourth chol quartile, and in the second HDL-chol quartile (data not shown).
Frequency distributions of chol and apoB in CADϩ and CADϪ women are shown in Figures 2 and 3 . Of the CADϩ women, 68.7% had an elevated apoB concentration (Ͼ1.3 g/L). Of the CADϪ women, 55.8% had a normal apoB concentration (Յ1.3 g/L). In the CADϩ group, chol concentration exceeded 6.5 mmol/l in 65%, an LDL-chol concentration Ͼ3.5 mmol/L was present in 90%, and LDL-chol concentrations were Ͼ2.5 mmol/L in 99% of the women. ApoB (Pϭ0.0003), chol (PϽ0.001), and LDL-chol (Pϭ0.0003) showed a linear increase with age expressed in 5-year intervals.
Discussion
In the current study we report the association between plasma apoB concentrations and CAD in women from the general population who were referred for angiography. Chol, LDLchol, HDL-chol, TGs, and apoB were independent risk factors for CAD in women after correction for nonlipid risk factors. ApoA-I was not related to CAD. ApoB was superior to the "traditional lipids" chol, LDL-chol, HDL-chol, and TG in predicting the presence or absence of CAD. In the lowest quartiles of chol, LDL-chol, and TG, CADϩ women still had higher apoB concentrations than CADϪ women. In the highest HDL-chol quartile, apoB concentrations were higher in CADϩ compared with CADϪ women, but this association only approached (Pϭ0.07) significance. In contrast, chol, LDL-chol, TGs, or HDL-chol gave no additional information for any apoB quartile. ApoB was also associated with the extent of CAD, expressed as the number of vessels involved, which has recently been reported to predict cardiovascular mortality. 17 The role of apoB as an important risk factor is biologically plausible, 18, 19 since plasma apoB concentrations reflect the number of atherogenic lipoprotein particles. 20 The atherogenic lipoproteins are LDL, containing predominantly chol, VLDL remnants (IDL), and chylomicron remnants, which contain both chol and TGs. LDL and remnant particles each contain 1 molecule of apoB as the structural protein, whereas the amount of chol and TGs per particle varies, and with it, the atherogenicity of the particle. Large, TG-rich VLDL particles are not considered atherogenic, 21 whereas smaller remnants of TG-rich lipoprotein particles are atherogenic. 22 Small, dense LDL particles are more atherogenic than are LDL particles of normal composition. 23 Increased small, dense LDL concentrations are reflected by a more pronounced elevation of LDL apoB than of LDL-chol, and this trend is often accompanied by elevated plasma TG concentrations. Chol is a constituent of both atherogenic, apoBcontaining lipoproteins and antiatherogenic, apoA-containing lipoproteins. This heterogeneity of lipoprotein particle composition can explain the superiority of apoB over chol and TG as a CAD risk factor. Prospective population-based studies have designated HDL-chol as the most powerful lipid risk factor in women, 4,5,24 -26 but in these studies apoB was not determined. Cross-sectional analysis of the Framingham Offspring population showed that apoB concentrations were related to CAD in women. 27 Data on apoB as a risk factor for CAD in the general population will also become available from a prospective, population-based observational study, including a large number of US women. 28 Although apoB was the best discriminant between CADϪ and CADϩ in the current study, there was still considerable overlap in apoB between CADϪ and CADϩ. Other studies have shown that the predictive power of apoB can be increased by separation of the plasma into different apoBcontaining lipoprotein fractions. The fasting remnant, or IDL fraction, was superior to the LDL fraction in predicting the presence 8 or severity 29 of CAD in women with premature CAD. Postprandial chylomicron remnant concentrations were higher in CADϩ than in CADϪ women while LDL apoB was similar.
12 IDL-chol was also related to the progression of CAD in a combined group of men and women (nϭ63) with premature CAD, 30 and IDL mass was related to the progression of carotid artery intima-media thickness in a study in men and women (nϭ24) combined. 31 Early data from Framingham showed that in women, and in particular in postmenopausal women, remnant chol was related to CAD. 32 Thus, in women, parameters for remnant particles are potentially better CAD risk indicators than is plasma apoB.
A limitation of the current study is the selection of women for angiography. Although only women who were undergoing their first angiography were included and women on lipid-lowering medication were excluded, the women who were suspected of having CAD could have changed their lifestyle. The CADϪ women, who were referred for angiography because of suspected CAD, were likely to have more risk factors compared with CADϪ women from the general population. These considerations would more likely underestimate than overestimate the strength of apoB as a risk factor. Still, the findings from the current study can be applied to women who are referred for angiography but cannot be extrapolated directly to the general population.
Currently, guidelines for CAD prevention are focussed on LDL-chol, although in women, LDL-chol is not a very powerful CAD risk factor. 4 For secondary prevention, the target level for LDL-chol is Յ2.6 mmol/L, and lipid-lowering therapy should be initiated if LDL-chol is Ն3.4 mmol/L. 33, 34 In the current study, 99% of CADϩ women had an LDL-chol concentration Ͼ2.6 mmol/L. Ninety percent of CADϩ women had an LDL-chol concentration Ն3.4 mmol/L, and therefore, had an indication for lipid-lowering interventions. A generally accepted apoB target level for prevention of cardiovascular disease may be defined in the future.
Hormonal Status
CAD is a disease of postmenopausal women. 6, 35 In the current study 95% of the CADϩ women were postmenopausal. Estrogen deficiency has been reported to be an independent risk factor for CAD assessed by angiography. 36 In the current study, menopause was no longer a CAD risk factor after correction for age. This was probably due to the relatively small number of premenopausal women. Therefore, another measure of exposure to endogenous estrogens was used: the age at menopause. Recently it has been reported that the age at menopause is inversely associated with cardiovascular mortality. 37 This association was not found in the Nurses' Health Study, 38 in which the population was rather young. In the current study the age at menopause was not associated with CAD after correction for age. These findings suggest that age is a more important factor than endogenous estrogens. Another explanation could be that the current study group is different from the general population. In addition, endogenous estrogens are potentially related to CAD through mechanisms that are not detectable on angiography, such as vascular wall reactivity. [39] [40] [41] [42] This would imply that angiography studies are not an appropriate tool to evaluate the effect of estrogens. Nevertheless, the effect of HRT on angiographically defined CAD has repeatedly been demonstrated [43] [44] [45] [46] and even linked to survival. 17 In the current study, few women ever used HRT, and the mean duration of HRT was short.
Nonlipid Risk Factors
Smoking emerged as a stronger risk factor than hypertension and diabetes. This also applied to the normolipidemic subgroup of women. Cessation of smoking has been reported to reduce CAD risk by 50% to 80% in observational studies. 47 In conclusion, in this community-based angiography study in women, plasma concentrations of apoB, reflecting the number of atherogenic lipoproteins, was the best lipoprotein or lipid discriminant between CADϪ and CADϩ. The majority of CADϩ women had an LDL Ͼ2.5 mmol/L, the target level for secondary prevention. The majority of the CADϩ women were also postmenopausal, and HRT has been associated with protection against CAD. 48 It remains to be determined which intervention, lipid lowering per se, HRT (also known to reduce apoB 49 -51 ), or a combination of both will be the best strategy.
